Expertise in
4
conditions

Sebastien Couraud

Faculté De Médecine Lyon Est, 
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Faculté De Médecine Lyon Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Sebastien Couraud practices in Lyon, France. Mr. Couraud is highly rated in 4 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Tissue Biopsy, and Endoscopy.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Faculté De Médecine Lyon Est, Lyon, 69008, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Enrollment Status: Recruiting
Publish Date: October 16, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Patients With Lung and Head and Neck Cancers, Treated With an Immunotherapy-based Therapy
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Patients With Lung and Head and Neck Cancers, Treated With an Immunotherapy-based Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Multicentre Phase II, Open-label, Non-randomized Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
A Multicentre Phase II, Open-label, Non-randomized Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drugs: Carboplatin+ Pemetrexed+Atezolizumab+Bevacizumab, Carboplatin+Pemetrexed+Atezolizumab
Study Phase: Phase 2
Chronic Fatigue Etiology and Recovery in Covid-19 Patients : the Role of Fatigability and Stay in Intensive Care
Chronic Fatigue Etiology and Recovery in Covid-19 Patients : the Role of Fatigability and Stay in Intensive Care
Enrollment Status: Terminated
Publish Date: March 25, 2025
Intervention Type: Device, Other, Biological
Study Phase: Not Applicable
An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
Enrollment Status: Terminated
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drug: KRT-232
Study Phase: Phase 2
Host-pathogen Interactions During Paediatric and Adult SARS-CoV-2 Infection (COVID-19)
Host-pathogen Interactions During Paediatric and Adult SARS-CoV-2 Infection (COVID-19)
Enrollment Status: Completed
Publish Date: April 05, 2023
Intervention Type: Biological, Other
Study Phase: Not Applicable
Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Other
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Enrollment Status: Terminated
Publish Date: October 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
Study of Smoking Prevalence at the Hospices Civils de Lyon
Study of Smoking Prevalence at the Hospices Civils de Lyon
Enrollment Status: Completed
Publish Date: June 11, 2018
Intervention Type: Other
View 8 Less Clinical Trials

120 Total Publications

Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020.
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020.
Journal: NEJM evidence
Published: June 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Couraud's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile